Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02495259 · ClinicalTrials.gov registry record · NA
Comparison of Double Lumen Tube Placement Techniques
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02495259: Clinical Trial NA study, sponsored by Emory University.
NCT02495259 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02495259, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to compare three different standard of care methods of double-lumen endobronchial tube (DLT) placement in patients who are scheduled to have thoracic surgery in which lung isolation is required.
Primary Outcome
The time taken for successful intubation will be recorded by the anesthetist. The total duration from the time the laryngoscope is placed at the patient's lips to the first detection of End-tidal CO2 (EtCO2), an average of 120 seconds, will be recorded in seconds. A higher duration noted is indicative of a longer time taken for successful intubation. 0 seconds (laryngoscope at patient's lips), (first End-tidal CO2 (EtCO2) detection)
Interventions
- DEVICE GlideScope
- DEVICE ZU-bend stylet
- DEVICE GlideRite stylet
- DEVICE Macintosh blade
- DEVICE Regular Double-lumen endobronchial tube (DLT) Stylet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-07-27 |
| Phase | NA |
Why NCT02495259 stopped before completion
NCT02495259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which GlideScope is the first listed.
NCT02495259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02495259 about?
NCT02495259 is a clinical study titled "Comparison of Double Lumen Tube Placement Techniques". The purpose of this study is to compare three different standard of care methods of double-lumen endobronchial tube (DLT) placement in patients who are scheduled to have thoracic surgery in which lung isolation is required.
What is the current status of trial NCT02495259?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2015-07. Estimated completion is 2017-07-27.
What interventions are being tested in trial NCT02495259?
The interventions under investigation include: GlideScope (DEVICE), ZU-bend stylet (DEVICE), GlideRite stylet (DEVICE), Macintosh blade (DEVICE), Regular Double-lumen endobronchial tube (DLT) Stylet (DEVICE).
Who is sponsoring clinical trial NCT02495259?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02495259's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia